Skip to content

Role of remote ischaemic preconditioning in human liver transplant - A prospective randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN32557472
Enrollment
Unknown
Registered
2004-11-19
Start date
2002-01-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Various liver conditions requiring liver transplant Not Applicable Liver transplant

Interventions

One group will receive livers with ischaemic preconditioning and the second group will be the control having routine liver transplant.

Sponsors

Cambridge University Hospitals NHS Foundation Trust - Addenbrooke's Hospital (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Liver transplant patients with first liver transplant

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration

Secondary

MeasureTime frame
Not provided at time of registration

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026